{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:54:51Z","timestamp":1770684891890,"version":"3.49.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/ja.2016.148","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T07:23:08Z","timestamp":1484119388000},"page":"264-271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In vitro antibacterial activity of \u03b1-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA"],"prefix":"10.1038","volume":"70","author":[{"given":"Hiroyuki","family":"Sugiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ippei","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Manaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,11]]},"reference":[{"key":"BFja2016148_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ijantimicag.2007.10.022","volume":"31","author":"DJ Farrell","year":"2008","unstructured":"Farrell, D. J., Couturier, C. & Hryniewicz, W. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004). Int. J. Antimicrob. Agents 31, 245\u2013249 (2008).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFja2016148_CR2","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1128\/AAC.05658-11","volume":"56","author":"SH Kim","year":"2012","unstructured":"Kim, S. H. et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob. Agents Chemother. 56, 1418\u20131426 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR3","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1128\/AAC.00185-16","volume":"60","author":"DJ Farrell","year":"2016","unstructured":"Farrell, D. J., Flamm, R. K., Sader, H. S. & Jones, R. N. Results from the Solithromycin International Surveillance Program (2014). Antimicrob. Agents Chemother. 60, 3662\u20133668 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR4","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1128\/AAC.01548-09","volume":"54","author":"E P\u00e9rez-Trallero","year":"2010","unstructured":"P\u00e9rez-Trallero, E. et al. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007). Antimicrob. Agents Chemother. 54, 2953\u20135959 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR5","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1093\/jac\/dkw116","volume":"71","author":"A Michos","year":"2016","unstructured":"Michos, A. et al. Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13). J. Antimicrob. Chemother. 71, 2113\u20132117 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2016148_CR6","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1099\/jmm.0.2008\/002642-0","volume":"57","author":"T Wajima","year":"2008","unstructured":"Wajima, T. et al. Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease. J. Med. Microbiol. 57, 1383\u20131388 (2008).","journal-title":"J. Med. Microbiol."},{"key":"BFja2016148_CR7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1128\/JCM.02383-13","volume":"52","author":"CY Huang","year":"2014","unstructured":"Huang, C. Y. et al. Epidemiology and molecular characterization of macrolide-resistant Streptococcus pyogenes in Taiwan. J. Clin. Microbiol. 52, 508\u2013516 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"BFja2016148_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10156-009-0021-4","volume":"16","author":"M Morozumi","year":"2010","unstructured":"Morozumi, M., Takahashi, T. & Ubukata, K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J. Infect. Chemother. 16, 78\u201386 (2010).","journal-title":"J. Infect. Chemother."},{"key":"BFja2016148_CR9","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1128\/AAC.00663-13","volume":"57","author":"Y Kawai","year":"2013","unstructured":"Kawai, Y. et al. Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients. Antimicrob. Agents Chemother. 57, 4046\u20134049 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR10","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1128\/AAC.02060-12","volume":"57","author":"F Zhao","year":"2013","unstructured":"Zhao, F. et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob. Agents Chemother. 57, 1521\u20131523 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR11","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1128\/AAC.46.9.2727-2734.2002","volume":"46","author":"R Leclercq","year":"2002","unstructured":"Leclercq, R. & Courvalin, P. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46, 2727\u20132734 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1046\/j.1365-2958.1999.01202.x","volume":"31","author":"LH Hansen","year":"1999","unstructured":"Hansen, L. H., Mauvais, P. & Douthwaite, S. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA. Mol. Microbiol. 31, 623\u2013631 (1999).","journal-title":"Mol. Microbiol."},{"key":"BFja2016148_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1046\/j.1365-2958.1999.01203.x","volume":"31","author":"L Xiong","year":"1999","unstructured":"Xiong, L., Shah, S., Mauvais, P. & Mankin, A. S. A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre. Mol. Microbiol. 31, 633\u2013639 (1999).","journal-title":"Mol. Microbiol."},{"key":"BFja2016148_CR14","doi-asserted-by":"publisher","first-page":"17152","DOI":"10.1073\/pnas.1007988107","volume":"107","author":"JA Dunkle","year":"2010","unstructured":"Dunkle, J. A., Xiong, L., Mankin, A. S. & Cate, J. H. Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action. Proc. Natl Acad. Sci. USA 107, 17152\u201317157 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"Suppl. B","key":"BFja2016148_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jac\/48.suppl_2.9","volume":"48","author":"R Leclercq","year":"2001","unstructured":"Leclercq, R. Overcoming antimicrobial resistance: profile of a new ketolide antibacterial, telithromycin. J. Antimicrob. Chemother. 48 (Suppl. B), 9\u201323 (2001).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2016148_CR16","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1086\/430067","volume":"40","author":"JR Lonks","year":"2005","unstructured":"Lonks, J. R. & Goldmann, D. A. Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections. Clin. Infect. Dis. 40, 1657\u20131664 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"BFja2016148_CR17","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1128\/AAC.01153-06","volume":"51","author":"N Wolter","year":"2007","unstructured":"Wolter, N., Smith, A. M., Low, D. E. & Klugman, K. P. High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 51, 1092\u20131095 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1128\/AAC.01074-07","volume":"52","author":"N Wolter","year":"2008","unstructured":"Wolter, N. et al. Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation. Antimicrob. Agents Chemother. 52, 435\u2013440 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. S1","key":"BFja2016148_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/jac\/dkf806","volume":"50","author":"DJ Farrell","year":"2002","unstructured":"Farrell, D. J., Morrissey, I., Bakker, S. & Felmingham, D. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. J. Antimicrob. Chemother. 50 (Suppl. S1), 39\u201347 (2002).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2016148_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/AAC.46.2.546-549.2002","volume":"46","author":"K Nagai","year":"2002","unstructured":"Nagai, K. et al. Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. Antimicrob. Agents Chemother. 46, 546\u2013549 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/jac\/dkg303","volume":"52","author":"MI Morosini","year":"2003","unstructured":"Morosini, M. I. et al. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin. J. Antimicrob. Chemother. 52, 50\u201355 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2016148_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1128\/AAC.46.1.125-131.2002","volume":"46","author":"A Canu","year":"2002","unstructured":"Canu, A. et al. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46, 125\u2013131 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/jac\/dkg348","volume":"52","author":"F Walsh","year":"2003","unstructured":"Walsh, F., Willcock, J. & Amyes, S. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae. J. Antimicrob. Chemother. 52, 345\u2013353 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2016148_CR24","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2174\/1568026033452140","volume":"3","author":"T Asaka","year":"2003","unstructured":"Asaka, T., Manaka, A. & Sugiyama, H. Recent developments in macrolide antimicrobial research. Curr. Top. Med. Chem. 3, 961\u2013989 (2003).","journal-title":"Curr. Top. Med. Chem."},{"key":"BFja2016148_CR25","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.2174\/15680266113136660223","volume":"13","author":"JH Liang","year":"2013","unstructured":"Liang, J. H. & Han, X. Structure-activity relationships and mechanism of action of macrolides derived from erythromycin as antibacterial agents. Curr. Top. Med. Chem. 13, 3131\u20133164 (2013).","journal-title":"Curr. Top. Med. Chem."},{"key":"BFja2016148_CR26","unstructured":"Asaka, T. et al 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract no. F-262, Toronto, Canada, (1997)."},{"key":"BFja2016148_CR27","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1021\/jm015566s","volume":"44","author":"T Tanikawa","year":"2001","unstructured":"Tanikawa, T. et al. Synthesis and antibacterial activity of acylides (3-O-acyl-erythromycin derivatives): a novel class of macrolide antibiotics. J. Med. Chem. 44, 4027\u20134030 (2001).","journal-title":"J. Med. Chem."},{"key":"BFja2016148_CR28","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1021\/jm020568d","volume":"46","author":"T Tanikawa","year":"2003","unstructured":"Tanikawa, T. et al. Synthesis and antibacterial activity of a novel series of acylides: 3-O-(3-pyridyl)acetylerythromycin A derivatives. J. Med. Chem. 46, 2706\u20132715 (2003).","journal-title":"J. Med. Chem."},{"key":"BFja2016148_CR29","unstructured":"Asaka, T. et al (Taisho Pharmaceutical Co., Ltd.). Erythromycin A derivatives. WO 1998023628 A1 (1998)."},{"key":"BFja2016148_CR30","unstructured":"Asaka, T. et al 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract no. F-2159, San Francisco, CA, USA, (1999)."},{"key":"BFja2016148_CR31","unstructured":"Asaka, T., Kashimura, M., Manaka, A., Tanikawa, T. & Sugimoto, T. (Taisho Pharmaceutical Co., Ltd.). Macrolide derivative. JP 2001072699A (2001)."},{"key":"BFja2016148_CR32","unstructured":"Kashimura, M., Kawamura, M., Asaka, T., Takayama, K. & Ogita, H. (Taisho Pharmaceutical Co., Ltd.). Macrolide derivative. WO 2007129646 A1 (2007)."},{"key":"BFja2016148_CR33","unstructured":"Asaka, T. et al (Taisho Pharmaceutical Co., Ltd.). Erythromycin A derivatives. WO 1998040392 A1 (1998)."},{"key":"BFja2016148_CR34","unstructured":"Clinical and Laboratory Standards Institute Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved Standard M7-A09, Clinical and Laboratory Standards Institute, Wayne, PA, USA, (2012)."},{"key":"BFja2016148_CR35","unstructured":"Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing. 22th Informational Supplement. M100-S22, Clinical and Laboratory Standards Institute, Wayne, PA, USA, (2012)."},{"key":"BFja2016148_CR36","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1128\/AAC.38.4.790","volume":"38","author":"K Ishida","year":"1994","unstructured":"Ishida, K. et al. In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 38, 790\u2013798 (1994).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR37","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1093\/nar\/24.22.4420","volume":"24","author":"R Himmelreich","year":"1996","unstructured":"Himmelreich, R. et al. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res. 24, 4420\u20134449 (1996).","journal-title":"Nucleic Acids Res."},{"key":"BFja2016148_CR38","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1128\/AAC.48.2.460-465.2004","volume":"48","author":"S Pereyre","year":"2004","unstructured":"Pereyre, S. et al. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 48, 460\u2013465 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR39","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1128\/AAC.48.12.4624-4630.2004","volume":"48","author":"M Matsuoka","year":"2004","unstructured":"Matsuoka, M. et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob. Agents Chemother. 48, 4624\u20134630 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR40","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1128\/JCM.39.7.2565-2571.2001","volume":"39","author":"L McGee","year":"2001","unstructured":"McGee, L. et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J. Clin. Microbiol. 39, 2565\u20132571 (2001).","journal-title":"J. Clin. Microbiol."},{"key":"BFja2016148_CR41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/INF.0b013e31827aa7bd","volume":"32","author":"Y Suzuki","year":"2013","unstructured":"Suzuki, Y. et al. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009. Pediatr. Infect. Dis. J. 32, 237\u2013240 (2013).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"BFja2016148_CR42","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/1471-2334-13-591","volume":"13","author":"K Matsuda","year":"2013","unstructured":"Matsuda, K. et al. Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan. BMC Infect. Dis. 13, 591 (2013).","journal-title":"BMC Infect. Dis."},{"key":"BFja2016148_CR43","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1128\/AAC.43.8.1935","volume":"43","author":"E Giovanetti","year":"1999","unstructured":"Giovanetti, E., Montanari, M. P., Mingoia, M. & Varaldo, P. E. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob. Agents Chemother. 43, 1935\u20131940 (1999).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.45.1.1-12.2001","volume":"45","author":"B Vester","year":"2001","unstructured":"Vester, B. & Douthwaite, S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob. Agents Chemother. 45, 1\u201312 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR45","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/jac\/45.4.547","volume":"45","author":"PM Furneri","year":"2000","unstructured":"Furneri, P. M., Rappazzo, G., Musumarra, M. P., Tempera, G. & Roccasalva, L. S. Genetic basis of natural resistance to erythromycin in Mycoplasma hominis. J. Antimicrob. Chemother. 45, 547\u2013548 (2000).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2016148_CR46","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/AAC.41.5.1162","volume":"41","author":"JI Ross","year":"1997","unstructured":"Ross, J. I. et al. Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob. Agents Chemother. 41, 1162\u20131165 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1749-6632.2011.06315.x","volume":"1241","author":"K Kannan","year":"2011","unstructured":"Kannan, K. & Mankin, A. S. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action. Ann. N. Y. Acad. Sci. 1241, 33\u201347 (2011).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"BFja2016148_CR48","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/jac\/dkl026","volume":"57","author":"S Pereyre","year":"2006","unstructured":"Pereyre, S., Renaudin, H., Charron, A., B\u00e9b\u00e9ar, C. & B\u00e9b\u00e9ar, C. M. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin. J. Antimicrob. Chemother. 57, 753\u2013756 (2006).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja2016148_CR49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","volume":"358","author":"S Tsiodras","year":"2001","unstructured":"Tsiodras, S. et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358, 207\u2013208 (2001).","journal-title":"Lancet"},{"key":"BFja2016148_CR50","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/AAC.05702-11","volume":"56","author":"KS Long","year":"2012","unstructured":"Long, K. S. & Vester, B. Resistance to linezolid caused by modifications at its binding site on the ribosome. Antimicrob. Agents Chemother. 56, 603\u2013612 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR51","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1128\/AAC.45.9.2604-2608.2001","volume":"45","author":"GE Kenny","year":"2001","unstructured":"Kenny, G. E. & Cartwright, F. D. Susceptibilities of Mycoplasma hominis M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob. Agents Chemother. 45, 2604\u20132608 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR52","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1128\/AAC.00090-09","volume":"53","author":"KB Waites","year":"2009","unstructured":"Waites, K. B., Crabb, D. M. & Duffy, L. B. Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101. Antimicrob. Agents Chemother. 53, 2139\u20132141 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR53","doi-asserted-by":"publisher","first-page":"13339","DOI":"10.1073\/pnas.0804276105","volume":"105","author":"DN Wilson","year":"2008","unstructured":"Wilson, D. N. et al. The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning. Proc. Natl Acad. Sci. USA 105, 13339\u201313344 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFja2016148_CR54","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1021\/jm800379d","volume":"51","author":"JA Ippolito","year":"2008","unstructured":"Ippolito, J. A. et al. Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit. J. Med. Chem. 51, 3353\u20133356 (2008).","journal-title":"J. Med. Chem."},{"key":"BFja2016148_CR55","doi-asserted-by":"publisher","first-page":"E5805","DOI":"10.1073\/pnas.1517952112","volume":"112","author":"Z Eyal","year":"2015","unstructured":"Eyal, Z. et al. Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus. Proc. Natl Acad. Sci. USA 112, E5805\u2013E5814 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFja2016148_CR56","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1128\/AAC.00644-10","volume":"54","author":"KS Long","year":"2010","unstructured":"Long, K. S. et al. Mutations in 23S rRNA at the peptidyl transferase center and their relationship to linezolid binding and cross-resistance. Antimicrob. Agents Chemother. 54, 4705\u20134713 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR57","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.chembiol.2010.06.003","volume":"17","author":"SC Blanchard","year":"2010","unstructured":"Blanchard, S. C., Cooperman, B. S. & Wilson, D. N. Probing translation with small-molecule inhibitors. Chem. Biol. 17, 633\u2013645 (2010).","journal-title":"Chem. Biol."},{"key":"BFja2016148_CR58","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/35101544","volume":"413","author":"F Schl\u00fcnzen","year":"2001","unstructured":"Schl\u00fcnzen, F. et al. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413, 814\u2013821 (2001).","journal-title":"Nature"},{"key":"BFja2016148_CR59","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1097-2765(02)00570-1","volume":"10","author":"JL Hansen","year":"2002","unstructured":"Hansen, J. L. et al. The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol. Cell 10, 117\u2013128 (2002).","journal-title":"Mol. Cell"},{"key":"BFja2016148_CR60","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.bmcl.2013.01.067","volume":"23","author":"TV Magee","year":"2013","unstructured":"Magee, T. V. et al. Novel 3-O-carbamoyl erythromycin A derivatives (carbamolides) with activity against resistant staphylococcal and streptococcal isolates. Bioorg. Med. Chem. Lett. 23, 1727\u20131731 (2013).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFja2016148_CR61","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1128\/AAC.00767-06","volume":"50","author":"R Berisio","year":"2006","unstructured":"Berisio, R., Corti, N., Pfister, P., Yonath, A. & B\u00f6ttger, E. C. 23S rRNA 2058A\u2192G alteration mediates ketolide resistance in combination with deletion in L22. Antimicrob. Agents Chemother. 50, 3816\u20133823 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016148_CR62","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1128\/AAC.00860-10","volume":"54","author":"B Llano-Sotelo","year":"2010","unstructured":"Llano-Sotelo, B. et al. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis. Antimicrob. Agents Chemother. 54, 4961\u20134970 (2010).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ja2016148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ja2016148","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ja2016148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T02:12:21Z","timestamp":1641003141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja2016148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,11]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFja2016148"],"URL":"https:\/\/doi.org\/10.1038\/ja.2016.148","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,11]]},"assertion":[{"value":"28 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}